Sellas Life Sciences Group Inc (SLS)
EBITDA Margin
0.00%
Quarterly · Period ending:
SLS EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
SLS Quarterly EBITDA Margin (0.00% → 0.00%)
Quarterly ebitda margin
High-resolution chart · PNG
SLS ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -1,669.8999% | |
| 0% | |
| 0% | |
| -242.7895% | |
| -24.5439% | |
| -214.8421% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 122.9289% | |
| 0% | |
| -266.1147% | |
| -320.5091% | |
| -349.2332% | |
| -639.6914% | |
| -667.2673% | |
| -534.6065% | |
| -916.1731% | |
| -578.2906% | |
| 0% | |
| 0% | |
| -910.9976% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -1,502.4691% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |